Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The human diet has changed dramatically over the last decade and today 64% of Britons are overweight.  Obesity is the main contributing factor to the development of type 2 diabetes (T2DM) and it is estimated that this will cost the  NHS  £16.9 billion per year by 2035.  Among current clinical treatments, however, gastrointestinal (GI) surgery remains the only approach capable of achieving significant, long-term sustained weight loss.  This is primarily attributed to a change in the physiology and appetite-regulating functions of gut hormones.  The cross-talk between gut hormones and their downstream target organs, as well as the role these peptides play in the regulation of food intake through appetite modulation, is therefore an area of intense research.  In this talk I will give a brief overview of what is currently known about gut peptides, their receptors and their endocrine control of energy metabolism.  I will also discuss my latest research into the gut hormone peptide,  GLP -1. 

If you have a question about this talk, please contact Sarah Noujaim.

DPAG Seminars